Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Benigni

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Contributions to Nephrology|January 1, 1989
Prevention of acute renal failure after aortic surgeryG Graziani, G Carabellese, E Lorenzano, et al.
Kidney International|April 1, 1984
The metabolism of arachidonic acid by platelets in nephrotic syndromeA Schieppati, P Dodesini, A Benigni, et al.
Kidney International|July 1, 1997
Renal and systemic nitric oxide synthesis in rats with renal mass reductionS Aiello, M Noris, M Todeschini, et al.
Kidney International|August 1, 1988
Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicityA Benigni, C Chiabrando, A Piccinelli, et al.
The New England Journal of Medicine|August 10, 1989
Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertensionA Benigni, G Gregorini, T Frusca, et al.
Kidney International|September 1, 1990
Role of enhanced glomerular synthesis of thromboxane A2 in progressive kidney diseaseP Salvati, C Ferti, R G Ferrario, et al.
Gene Therapy|March 28, 2017
AAV9-mediated engineering of autotransplanted kidney of non-human primatesS Tomasoni, P Trionfini, N Azzollini, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
Gene Therapy|November 4, 2016
Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunctionD Vavrincova-Yaghi, L E Deelman, H van Goor, et al.
Gene Therapy|July 26, 2016
Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunctionD Vavrincova-Yaghi, L E Deelman, H van Goor, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Contributions to Nephrology|January 1, 1989
Prevention of acute renal failure after aortic surgeryG Graziani, G Carabellese, E Lorenzano, et al.
Kidney International|April 1, 1984
The metabolism of arachidonic acid by platelets in nephrotic syndromeA Schieppati, P Dodesini, A Benigni, et al.
Kidney International|July 1, 1997
Renal and systemic nitric oxide synthesis in rats with renal mass reductionS Aiello, M Noris, M Todeschini, et al.
Kidney International|August 1, 1988
Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicityA Benigni, C Chiabrando, A Piccinelli, et al.
The New England Journal of Medicine|August 10, 1989
Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertensionA Benigni, G Gregorini, T Frusca, et al.
Kidney International|September 1, 1990
Role of enhanced glomerular synthesis of thromboxane A2 in progressive kidney diseaseP Salvati, C Ferti, R G Ferrario, et al.
Gene Therapy|March 28, 2017
AAV9-mediated engineering of autotransplanted kidney of non-human primatesS Tomasoni, P Trionfini, N Azzollini, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
Gene Therapy|November 4, 2016
Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunctionD Vavrincova-Yaghi, L E Deelman, H van Goor, et al.
Gene Therapy|July 26, 2016
Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunctionD Vavrincova-Yaghi, L E Deelman, H van Goor, et al.
Pageof 15